Jaye Thompson Insider Profile

4 Followers
Jaye Thompson, SVP Clinical Dev & Reg Affairs at Acer Therapeutics, holds 262.35K shares in Greenwich LifeSciences (Ticker: GLSI), holds 4.31K shares in Acer Therapeutics (Ticker: ACER), holds 0.00 shares in Repros (Ticker: ~RPRX). Most recently, Jaye Thompson Bought ― shares of Greenwich LifeSciences on Aug 05, 2024 for an estimated value of 15.15K.
tipranks
Jaye Thompson

Jaye Thompson
Acer Therapeutics (ACER)
SVP Clinical Dev & Reg Affairs

Ranked #27,663 out of 98,496 Corporate Insiders

Profitable Transactions

37%
7 out of 19 Profitable Transactions

Average Return

+2.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
100.00%
A breakdown of Jaye Thompson's holdings

Insider Roles

Greenwich LifeSciences
(GLSI)
VP Clinical Reg Affairs
Roles that Jaye Thompson holds in companies

Most Profitable Insider Trade

Stock:
Greenwich LifeSciences
(GLSI)
Rating:Informative Buy
Date:Oct 31, 2023 - Today
Return:+77.90%
The most profitable trade made by Jaye Thompson

Jaye Thompson's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ACER
Acer Therapeutics
Nov 30, 2009
Uninformative Buy
$2.85K
Greenwich LifeSciences
Aug 05, 2024
VP Clinical Reg Affairs
Informative Buy
15.15K
$3.90M
~RPRX
Repros
$0.00
List of latest transactions for each holding click on a transaction to see Jaye Thompson's performance on stock

Jaye Thompson insider profile FAQ

What is the percentage of profitable transactions made by Jaye Thompson?
The percentage of profitable transactions made by Jaye Thompson is 37%.
    What is the average return per transaction made by Jaye Thompson?
    The average return per transaction made by Jaye Thompson is 2.30%.
      What stocks does Jaye Thompson hold?
      Jaye Thompson holds: ACER, GLSI, ~RPRX stocks.
        What was Jaye Thompson’s latest transaction?
        Jaye Thompson latest transaction was an Informative Buy of $15.15K.
          What was Jaye Thompson's most profitable transaction?
          Jaye Thompson’s most profitable transaction was an Informative Buy of GLSI stock on October 31, 2023. The return on the trade was 77.90%.
            What is Jaye Thompson's role in Acer Therapeutics?
            Jaye Thompson's role in Acer Therapeutics is SVP Clinical Dev & Reg Affairs.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.